Mar 06, 2019
Autoimmune Disease Therapeutics Market to Reach $153.32 Billion, Globally, by 2025 at 4.2% CAGR: Allied Market Research
Jan 18, 2019
Global Myasthenia Gravis Market 2017-2018 & 2026: Increase in Occurrence of Autoimmune Disorders and Strong Pipeline Propelling Market Growth
Jan 16, 2019
BlueRock Therapeutics Establishes Key Partnerships with Leading Experts in Autoimmune Disease
Jan 14, 2019
Newly discovered phagocyte plays role in autoimmune disease
Jan 11, 2019
Benaroya Research Institute Team Finds Link Between New Type Of Cell And A Deadly Inflammatory Disorder
Jan 10, 2019
Lupus Research Alliance Announces Translational Research Grants to Speed Development of New Treatments
Jan 08, 2019
Regen BioPharma, Inc. Examines Combining Cannabidiol (CBD) With Its Lead NR2F6 Agonist To Treat for Inflammatory Bowel Disease
Jan 02, 2019
uBiome Receives Patent for Diagnostics and Therapeutics for Autoimmune Disorders
Dec 20, 2018
Kypha Secures $4M Series A Funding to Accelerate First-in-Class Diagnostic Platform Commercialization
Dec 20, 2018
Two Outstanding Scientists Recognized for Transformative Lupus Research Projects
Dec 13, 2018
FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)
Dec 12, 2018
Announcing the Allen Institute for Immunology, a new research endeavor focused on human immune health and disease
Dec 06, 2018
Berlin Cures' Steering Committee is Assembled to Facilitate the Design and Implementation of Phase 2 Study of BC 007
Nov 28, 2018
Provention Bio Joins the C-Path Type 1 Diabetes (T1D) Consortium
Nov 20, 2018
Self-Administered Autoimmune Injectables (mAbs, Cytokines & Fusion Proteins) Market, 2022
Nov 20, 2018
Biological Autoimmune Therapeutics Market, 2018-2022: Regulatory Factors, United State/FDA, Europe/EMA, Clinical Trial Protocols & Endpoints & Alliances and Partnerships
Nov 15, 2018
Self-Administered Autoimmune Injectables
Nov 07, 2018
Immunovia Interim Report January-September 2018
Oct 29, 2018
Global Autoimmune Partnering 2012-2018: Deal trends, players and financials
Oct 25, 2018
AMPEL's System For Drug Repositioning Confirmed By Success Of Phase 2 Trial Of Stelara In Lupus